Nestor Healthcare Group acquired by Saga Group

UNITED KINGDOM Health Providers / Outpatient Care EV £100–350M

Context

Saga acquired 100% of Nestor Healthcare Group via a public takeover. The acquisition establishes Saga as a nationwide home care provider by combining Nestor's Northern England care network with Saga's existing Southern operations, creating full national coverage. The strategic rationale centres on Saga's ambition to build a major nationally branded home healthcare business for its core over-50s customer base, accelerating its growth strategy in home healthcare services.

Nestor Healthcare Group, which reported an EBITDA margin of [members only] in 2009, is valued in this transaction at an EV/EBITDA multiple of 10x–18x, to compare with the average currently observed in the Healthcare & Pharma sector (14.3x in 2026).

-> Deep-dive in Healthcare & Pharma market trends

Target

Nestor Healthcare Group is a UK-based provider of managed social and primary care services, specialising in domiciliary care (home-based care services). The company operates a broad care network primarily concentrated in the North of England, providing in-home support and personal care services to elderly and vulnerable individuals on behalf of local authorities and NHS commissioners. Nestor had built a strong operational footprint across Northern England, with an established network of care workers delivering a range of services including personal care, companionship, and managed social care.

Ent. Value

£100–350M

Equity Value

[members only]

Multiples

EV / Revenue

below 1.5x

EV / EBITDA

10x–18x

EV / EBIT

10x–18x

Historical Financials (GBP)

Year

Rev

EBITDA

EBIT

2009

2008

Similar deals in Health Providers

Similar deals in Health Providers
Date	Acquirer	Target	Country	Sector
01/2015	CERBA HEALTHCARE	NOVESCIA	FRANCE	Labs (Biology)
10/2014	WATERLAND	MEDIAN KLINIKEN	GERMANY	Clinics / Hospitals
09/2014	EURAZEO	COLISÉE	FRANCE	Nursing Homes
06/2014	PAI PARTNERS	DOMUSVI	FRANCE	Nursing Homes
03/2014	EQT PARTNERS	I-MED RADIOLOGY NETWORK	AUSTRALIA	Radiology
07/2012	MANAGEMENT & PRIVATE INVESTORS	LVL MEDICAL GERMANY	GERMANY	Outpatient Care
06/2012	AIR LIQUIDE	ORKYN (EX LVL MEDICAL)	FRANCE	Outpatient Care
06/2010	PAI PARTNERS	CERBA HEALTHCARE	FRANCE	Labs (Biology)
05/2010	HG CAPITAL	FRÖSUNDA	SWEDEN	Healthcare Facilities
03/2010	BRIDGEPOINT	CARE UK	UNITED KINGDOM	Nursing Homes

REFERENCES

Valuation range: EV £100–350M

Revenue range: £100–200M

EBITDA range: £5–25M

EV/Revenue range: below 1.5x

EV/EBITDA range: 10x - 18x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Nestor Healthcare Group by Saga Group are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: saga group

FAQ

What transaction does this page cover?

This page covers Saga Group’s acquisition of 100% of Nestor Healthcare Group, a British company specialised in Outpatient Care, in 2010.

How was the acquisition of Nestor Healthcare Group by Saga Group valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the £100–350M band, its EV/EBITDA multiple within the 10x - 18x range, and its EV/revenue multiple within the below 1.5x range. Exact figures are available to members.

What were Nestor Healthcare Group’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Nestor Healthcare Group generated annual revenue estimated in the £100–200M range and EBITDA in the £5–25M bracket (FY 2009). Detailed financial figures are available to members.

How does the valuation of Nestor Healthcare Group compare to benchmarks in the Healthcare & Pharma sector?

With an estimated valuation multiple in the range of 10x - 18x in 2010, the transaction reflects historical valuation standards. By way of comparison, in 2026 companies in the Healthcare & Pharma sector are valued at a multiple of 14.3x EBITDA.

What sources support the information on this transaction?

Transaction intelligence is supported by independent reporting from specialized financial publications, alongside a private document shared by the community and verified by the mynth team to ensure the accuracy of the shared information.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.